Calamos Advisors

Calamos Advisors’s Psyence Biomedical Warrant PBMWW Stock Holding History

Calamos Advisors’s Portfolio PBMWW Stock Details PBMWW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.05K	Hold	500,000	–	–	﹤0.01%	1175
2025 Q4	$9.85K	Hold	500,000	–	–	﹤0.01%	897
2025 Q3	$12.5K	Hold	500,000	–	–	﹤0.01%	890
2025 Q2	$10.1K	Hold	500,000	–	–	﹤0.01%	884
2025 Q1	$8.45K	Hold	500,000	–	–	﹤0.01%	873
2024 Q4	$6.15K	Hold	500,000	–	–	﹤0.01%	877
2024 Q3	$6.35K	Hold	500,000	–	–	﹤0.01%	895
2024 Q2	$5.3K	Hold	500,000	–	–	﹤0.01%	907
2024 Q1	$35.8K	Buy	+500,000	New	+$31.1K	﹤0.01%	832

Other funds holding PBMWW

Harraden Circle Investments New York $499M AUM 24.03% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $4.21B AUM 35.27% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Toronto Dominion Bank

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $51.9B AUM 40.86% 1-Year Est. Return

Saba Capital Management New York $3.12B AUM 13% 1-Year Est. Return

Clear Street New York $17.8B AUM 56.26% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.36B AUM 24.94% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

LMR Partners London, United Kingdom $10.9B AUM 60.68% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return